Silk Road Medical Inc

This committee controls taxation, trade, and entitlement spending (e.g., Medicare, Medicaid). Its decisions on Medicare pricing, reimbursement rates for medical procedures and devices, and corporate tax policy directly impact Silk Road Medical's revenue, profitability, and market access.

This committee directly allocates federal discretionary spending, including funding for healthcare programs (e.g., NIH, VA, Medicare/Medicaid administration). Its decisions directly determine the 'cash flow' for federal entities that purchase or fund medical devices.

This committee directly regulates the FDA, which is the primary approval and oversight body for medical devices. Its decisions on drug and device approvals, as well as broader healthcare policy, directly impact Silk Road Medical's product viability and market access.

This committee directly oversees the Department of Veterans Affairs, and its funding decisions explicitly impact 'medical device manufacturers.' This provides a direct channel for influence over a significant potential customer base for Silk Road Medical.